Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model
- Authors
- Giday, S. A.; Kim, Y.; Krishnamurty, D. M.; Ducharme, R.; Liang, D. B.; Shin, E. J.; Dray, X.; Hutcheon, D.; Moskowitz, K.; Donatelli, G.; Rueben, D.; Canto, M. I.; Okolo, P. I.; Kalloo, A. N.
- Issue Date
- 4월-2011
- Publisher
- GEORG THIEME VERLAG KG
- Citation
- ENDOSCOPY, v.43, no.4, pp.296 - 299
- Indexed
- SCIE
SCOPUS
- Journal Title
- ENDOSCOPY
- Volume
- 43
- Number
- 4
- Start Page
- 296
- End Page
- 299
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/112697
- DOI
- 10.1055/s-0030-1256125
- ISSN
- 0013-726X
- Abstract
- Background and study aim: Endoscopic therapy of brisk upper gastrointestinal bleeding remains challenging. A proprietary nanopowder (TC-325) has been proven to be effective in high pressure bleeding from external wounds. The efficacy and safety of TC-325 were assessed in a survival gastrointestinal bleeding animal model. Method: 10 animals were randomized to treatment or sham. All animals received intravenous antibiotics, H2-blockers and heparin (activated clotting time 2 x normal). In a sterile laparotomy the gastroepiploic vessels were dissected, inserted through a 1-cm gastrotomy, and freely exposed in the gastric lumen, and the exposed vessel lacerated by needle knife. The treatment group received TC-325 by a modified delivery catheter while the sham group received no endoscopic treatment. Time to hemostasis, and mortality at 60 minutes, 24 hours, 48 hours, and 7 days were noted. Necropsy was performed in all animals. Results: Spurting arterial bleeding was achieved in all animals. No control animal showed hemostasis within the first hour compared with 100% (5/5) in the treatment arm (mean 13.8 minutes, P < 0.0079). Durable hemostasis was achieved with no evidence of rebleeding after 1 and 24 hours in 80% (4/5) of the treated animals compared with none in the control group (P < 0.0098). None of the control animals survived more than 6 hours. Necropsy at 1 week in treated animals revealed healed gastrotomy without foreign body granuloma or embolization to the lung or brain. Conclusion: TC-325 is safe and highly effective in achieving hemostasis in an anticoagulated severe arterial gastrointestinal bleeding animal model.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.